Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAINBOW-Hx: HUFF-01 in Chronic Intracerebral Hemorrhage
NCT06361433Phase 2Active, not recruiting
- Sponsor
- Hokkaido University Hospital
- Start
- Dec 2023
- Primary completion
- Sep 2027
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of HUFF-01 in intracerebral hemorrhage (ICH), sponsored by Hokkaido University Hospital. Started Dec 2023; status: active, not recruiting.
02
Drugs
HUFF-01
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT06361433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06361433.